These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8481545)

  • 21. Study of pituitary secretion in relation to retinopathy in patients with juvenile diabetes mellitus.
    Cerasola GA; Donatelli M; Sinagra D; Russo V; Amico LM; Lodato G
    Acta Diabetol Lat; 1981; 18(4):319-28. PubMed ID: 6277121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy.
    Wilkinson-Berka JL; Wraight C; Werther G
    Curr Med Chem; 2006; 13(27):3307-17. PubMed ID: 17168853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary growth hormone levels measured by ultrasensitive enzyme immunoassay in patients with renal insufficiency.
    Hattori N; Kato Y; Murakami Y; Hashida S; Ishikawa E; Mohri Z; Imura H
    J Clin Endocrinol Metab; 1988 Apr; 66(4):727-32. PubMed ID: 3279063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes.
    Reutrakul S; Siwasaranond N; Nimitphong H; Saetung S; Chirakalwasan N; Chailurkit LO; Srijaruskul K; Ongphiphadhanakul B; Thakkinstian A
    Chronobiol Int; 2017; 34(3):382-392. PubMed ID: 28128991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levodopa-stimulated growth hormone secretion and diabetic retinopathy.
    Holland PM; Landers MB; Lebovitz HE; Wolbarsht ML
    Am J Ophthalmol; 1976 Oct; 82(4):612-8. PubMed ID: 970425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erytrocyte membrane anionic charge in type 2 diabetic patients with retinopathy.
    Budak Y; Demirci H; Akdogan M; Yavuz D
    BMC Ophthalmol; 2004 Oct; 4():14. PubMed ID: 15473902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary excretion of GH in healthy individuals and patients with acromegaly, hypopituitarism and dwarfism.
    Quade A; Rahn M; Schweikert HU; Bidlingmaier F; Klingmüller D
    Acta Endocrinol (Copenh); 1993 Jan; 128(1):24-8. PubMed ID: 8447191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Secretion of GH and diabetic retinopathy].
    Greco AV; Ricci B; Ghirlanda G; Fedeli G; Altomonte L; Rebuzzi A
    Minerva Med; 1976 Sep; 67(45):2902-18. PubMed ID: 967359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone response to hyperinsulinaemia in insulin-dependent diabetics. Comparison of patients with and without retinopathy.
    Sharp PS; Foley K; Vitelli F; Maneschi F; Kohner EM
    Diabet Med; 1984 May; 1(1):55-8. PubMed ID: 6242779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regarding the role of growth hormone in the development of diabetic retinopathy.
    McGowan LM; Kiser WR
    Diabetes Care; 1995 Mar; 18(3):422-3. PubMed ID: 7555494
    [No Abstract]   [Full Text] [Related]  

  • 31. Urinary growth hormone excretion in diabetic children: relation to nocturnal course of blood glucose levels.
    Lebl J; Schober E; Frisch H; Sagmeister S; Häusler G
    Horm Res; 1993; 40(5-6):204-8. PubMed ID: 8112721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin analogues may accelerate progression of diabetic retinopathy after impairment of inner blood-retinal barrier.
    Kaya A; Kar T; Aksoy Y; Özalper V; Başbuğ B
    Med Hypotheses; 2013 Dec; 81(6):1012-4. PubMed ID: 24090664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus.
    Lunetta M; Infantone L; Calogero AE; Infantone E
    Diabetes Res Clin Pract; 1998 Apr; 40(1):45-51. PubMed ID: 9699090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary growth hormone (GH) measurements are useful for evaluating endogenous GH secretion.
    Sukegawa I; Hizuka N; Takano K; Asakawa K; Horikawa R; Hashida S; Ishikawa E; Mohri Z; Murakami Y; Shizume K
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1119-23. PubMed ID: 3286672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of proliferative diabetic retinopathy.
    Klein R; Klein BE; Moss SE
    Diabetes Care; 1992 Dec; 15(12):1875-91. PubMed ID: 1464243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass-spectrometry in type 2 diabetes to assess polyol pathway activity.
    Yoshii H; Uchino H; Ohmura C; Watanabe K; Tanaka Y; Kawamori R
    Diabetes Res Clin Pract; 2001 Feb; 51(2):115-23. PubMed ID: 11165691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Severe diabetic retinopathy and renal function in non-insulin-dependent (type-2) diabetes mellitus].
    Lugari R; Scoccianti L; Sborbone P; Bianco M; Dell'Anna C; Barilli LA; Gnudi A
    Minerva Endocrinol; 1995 Jun; 20(2):127-34. PubMed ID: 8531894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone and endothelial function during exercise in diabetics with and without retinopathy.
    Sundkvist G; Almér LO; Lilja B; Pandolfi M
    Acta Med Scand; 1984; 215(1):55-61. PubMed ID: 6421091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma thrombomodulin concentration in diabetes mellitus.
    Oida K; Takai H; Maeda H; Takahashi S; Tamai T; Nakai T; Miyabo S; Ishii H
    Diabetes Res Clin Pract; 1990 Oct; 10(2):193-6. PubMed ID: 2175697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic retinopathy and microalbuminuria in lean type 2 diabetes mellitus.
    Singh SK; Behre A; Singh MK
    J Assoc Physicians India; 2001 Apr; 49():439-41. PubMed ID: 11762615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.